The monoclonal antibody is the first non-factor, once-weekly treatment approved in the United States for hemophilia B.

A new study highlights the potential of using smartphone data collected in real-world situations for the early detection of ...

Only 13.4% immunocompromised adult US veterans younger than 50 years received the recombinant zoster vaccine by mid-2023, ...

Evidence suggested there is little risk in administering the live rotavirus vaccine to the babies of mothers on biologics ...

Delays in cancer registration probably led to a major underestimation of the effectiveness of screening colonoscopy in ...

The imaging agent Gleolan is only approved for glioma surgery, so the current trial could lead to a new indication. In this ...

Testing rates for mismatch repair and microsatellite instability among patients with CRC increased from 2012 to 2021, but ...

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was linked to an overall 3% increase in self-reported ...

New phase 3 results should reopen discussion about the off-label use of COMT inhibitors in early Parkinson's disease, experts ...

High caffeine intake can stimulate diuresis, but without causing damaging effects on hydration when taking moderate doses of ...

After decades of research, the field of focused ultrasound is exploding with new advances — promising safer, more effective ...

Data suggested that physician empathy has high therapeutic value for patients with chronic pain, compared with many pain ...